FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fludarabine Phosphate for Injection, USP
Status: Discontinuation
»Therapeutic Categories: Oncology

Hospira, Inc. (New 02/10/2020)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
50 mg Single Dose Glass Fliptop Vial (NDC 61703-0344-18) 02/10/2020 Discontinuation of the manufacture of the drug due to Active Pharmaceutical Ingredient Supplier market exit. Current supply expected to exhaust August 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English